🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Soft Tissue Sarcoma (STS)

Sarcoma Preoperative Radiation With Simultaneous INTegrated Boost (SPRINT) NCT05761054NA1 site📍 Florence Azienda Ospedaliero-Universitaria Careggi · Tests: RT SAVE Studie- SArcoma Surgery With Vacuum Enhanced Wound Treatment Randomised Study to Evaluate the Wound Management in Sarcoma Surgery NCT06889532NA1 site📍 Hamburg Universitätsklinikum Hamburg-Eppendorf · Tests: Intervention Group: In this group, a vacuum-assisted closure (VAC) system is applied intraoperatively to seal the wound… SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma NCT03138161Phase 1, Phase 21 site📍 Santa Monica Sarcoma Oncology Research Center, LLC · Tests: Trabectedin, Ipilimumab, Nivolumab A Phase II Study on Adjuvant Vaccination with Dendritic Cells Loaded with Autologous Tumor Homogenate in Resected Stage IV Rare Cancers. NCT04166006Phase 21 site📍 Meldola Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IR… · Tests: Autologous DC vaccine, Interleukin-2 Preoperative 5-Day Radiotherapy for Soft Tissue Sarcoma NCT06905132Phase 21 site📍 Charleston Medical University of South Carolina · Tests: Hypofractionated Radiation Therapy PET-imaging of Two Vartumabs in Patients With Solid Tumors NCT06645808EARLY Phase 11 site📍 Groningen Var2 Pharmaceuticals · Tests: 89Zr-DFO-N-Suc-F8scFv, 89Zr-DFO-N-Suc-C9scFv, PET/CT scan BAL Fluid Biomarkers in Sarcoma NCT06815666Phase 21 site📍 Toronto University Health Network, Toronto · Tests: Bronchoscopy & Metastasectomy Bridging Adolescent and Young Adult Sarcoma Survivors With Personalized Oncology Exercise Service (AYA-ONE): A Pilot Intervention NCT07662239NA3 sites📍 Boston📍 Boston📍 Boston Dana-Farber Cancer Institute · Tests: Exercise Triage and Personalized Exercise Program A Phase Ib/II Study to Evaluate Safety and Efficacy of Bexmarilimab in Combination With Doxorubicin in Metastatic Soft-tissue Sarcoma. NCT07460986Phase 1, Phase 211 sites📍 Badalona📍 Barakaldo📍 Barcelona MedSIR · Tests: bexmarilimab, Doxorubicin A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors NCT06700070EARLY Phase 11 site📍 Shreveport Pure Biologics S.A. · Tests: PBA-0111 Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers NCT06967961NA1 site📍 Toulouse Institut Claudius Regaud · Tests: For each enrolled patient, the sample described below will be collected as specific intervention intended for research … Study Comparing Negative Pressure Dressing vs Conventional in Patients With Resected STS After Radiotherapy NCT05944913NA15 sites📍 Nantes📍 Lyon📍 Angers Centre Leon Berard · Tests: Prevena Spatially Fractionated Radiotherapy Versus Conventional Radiotherapy in the Treatment of Soft Tissue Sarcoma NCT06980259NA1 site📍 Jinan Shandong Cancer Hospital and Institute · Tests: Spatially Fractionated Radiotherapy, Conventional Radiotherapy Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma. NCT07173972Phase 22 sites📍 Bergen📍 Oslo Oslo University Hospital · Tests: Definitive radiotherapy Exercise and Soft Tissue Sarcoma NCT04921917NA1 site📍 Durham Duke University · Tests: neoadjuvant exercise therapy Cryoablation Plus Camrelizumab for Advanced Soft Tissue Sarcoma NCT07602049Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Cryoablation therapy + anti-PD-1 antibody Efficacy and Safety of Cadonilimab Plus Anlotinib in Advanced STS That Failed the Previous First-line Standard Treatment NCT05926700Phase 21 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Candonilimab Sarcoma Care Adherence and Survival in Strasbourg NCT07864870n/a1 site📍 Strasbourg University Hospital, Strasbourg, France Fluorescence-Guided Optimization of Sarcoma Margins NCT07134192NA2 sites📍 Aarhus N📍 Copenhagen University of Aarhus · Tests: Fluorescent-guided Surgery Cirtuvivint in Selected Advanced Soft-Tissue Sarcomas NCT07032285Phase 21 site📍 Madrid Asociación Europea y Latinoamericana SELNET para la Investi… · Tests: Cirtuvivint A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma NCT07741877Phase 22 sites📍 Tampa📍 New York Iovance Biotherapeutics, Inc. · Tests: Lifileucel Umbilical Cord Blood NK Cell Therapy for High-Risk Pediatric Soft Tissue Sarcoma: Efficacy and Safety Study NCT06848582NA2 sites📍 Guangzhou📍 Dongguan Sun Yat-sen University · Tests: umbilical cord blood NK cells Development of a Radiomics Model With MR to Predict the Occurence of a Infiltration of Muscoskeletal Tumor NCT06774729n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna tTF-NGR Randomized Study - STS NCT05597917Phase 39 sites📍 Bad Saarow📍 Berlin📍 Dresden Universität Münster · Tests: Trabectedin, tTF-NGR Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients NCT07432932n/a1 site📍 London Royal Marsden NHS Foundation Trust · Tests: Observational Translational Study Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors NCT07630961Phase 12 sites📍 Odense C📍 Chuo Ku Novartis Pharmaceuticals · Tests: 68Ga-DFC413, 68Ga-NNS309 Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors NCT07261631Phase 19 sites📍 Princeton📍 Montreal📍 Odense C Novartis Pharmaceuticals · Tests: 68Ga-NNS309, 177Lu-DFC413 Tumor Neoantigen Vaccine SarVac Combined With Tumor Specific Lymphocyte Reinfusion in the Treatment of Advanced Sarcoma NCT07648069Phase 11 site📍 Guangzhou Sun Yat-sen University · Tests: Neoantigen vaccine + specific lymphocytes + anti-PD1 antibody, Neoantigen vaccine + anti-PD1 antibody A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08) NCT05824975Phase 1, Phase 211 sites📍 Scottsdale📍 Jacksonville📍 Rochester GI Innovation, Inc. · Tests: GI-102 subcutaneous (SC), GI-102, doxorubicin, paclitaxel, bevacizumab SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radiation Therapy and Adjuvant Atezolizumab in Patients With High-risk Surgically Resectable Extremity and Truncal Soft Tissue Sarcoma NCT07049848Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Atezolizumab, Doxorubicin Hydrochloride
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy